Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 305,744 | 252,721 | 274,992 | 289,897 | 233,351 |
| Receivables | 23,790 | 32,685 | 27,035 | 20,288 | 24,672 |
| Inventories | 9,862 | 11,614 | 14,315 | 2,291 | 1,404 |
| TOTAL | $346,462 | $301,187 | $320,345 | $317,993 | $266,150 |
| Non-Current Assets | |||||
| PPE Net | 15,066 | 13,975 | 13,126 | 12,291 | 11,923 |
| Investments And Advances | 0 | 56,860 | 48,484 | 23,479 | 17,566 |
| Intangibles | 12,552 | 13,043 | 13,701 | 14,442 | 14,629 |
| Other Non-Current Assets | 22,423 | 22,768 | 22,502 | 22,838 | 23,145 |
| TOTAL | $50,041 | $106,646 | $97,813 | $73,050 | $67,263 |
| Total Assets | $396,503 | $407,833 | $418,158 | $391,043 | $333,413 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 812 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 90,660 | 82,929 | 59,906 | 39,181 | 45,389 |
| TOTAL | $101,042 | $103,213 | $70,602 | $53,820 | $51,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46,564 | 46,108 | 58,698 | 57,599 | 59,814 |
| Deferred Revenues | 2,611 | 3,354 | 4,800 | 7,200 | N/A |
| Other Non-Current Liabilities | 59,963 | 71,124 | 61,413 | 52,643 | 40,035 |
| TOTAL | $69,584 | $92,152 | $99,255 | $92,998 | $84,654 |
| Total Liabilities | $170,626 | $195,365 | $169,857 | $146,818 | $136,414 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,970 | 6,645 | 6,741 | 6,491 | 6,330 |
| Common Shares | 101 | 464 | 360 | 97 | 95 |
| Retained earnings | -547,463 | -515,898 | -495,117 | -491,582 | -482,760 |
| Other shareholders' equity | 117,203 | 119,810 | 140,020 | 138,323 | 96,661 |
| TOTAL | $225,877 | $212,468 | $248,301 | $244,225 | $196,999 |
| Total Liabilities And Equity | $396,503 | $407,833 | $418,158 | $391,043 | $333,413 |